Chicago Capital, LLC’s Albireo Pharma Inc Position
Does Chicago Capital, LLC own Albireo Pharma Inc (BDQM)? Not currently — the last reported position was 1.36M shares worth $29M in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$29M
Q4 2022
Shares
1.36M
% of Portfolio
+1.63%
Quarters Held
17
position exited
Position History BDQM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2022 | 1.36M | $29M | +1.63% |
| Q3 2022 | 1.12M | $22M | +1.25% |
| Q2 2022 | 1.35M | $27M | +1.48% |
| Q1 2022 | 1.01M | $30M | +1.30% |
| Q4 2021 | 849.2K | $20M | +0.74% |
| Q3 2021 | 819.7K | $26M | +0.97% |
| Q2 2021 | 697.2K | $25M | +0.96% |
| Q1 2021 | 686.3K | $24M | +1.02% |
| Q4 2020 | 618.3K | $23M | +1.04% |
| Q3 2020 | 510.4K | $17M | +0.88% |
| Q2 2020 | 502.2K | $13M | +0.77% |
| Q1 2020 | 492.9K | $8M | +0.65% |
| Q4 2019 | 175.3K | $4M | +0.27% |
| Q3 2019 | 222.5K | $4M | +0.30% |
| Q2 2019 | 202.2K | $7M | +0.42% |
| Q1 2019 | 189.4K | $6M | +0.41% |
| Q4 2018 | 180.9K | $4M | +0.36% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Chicago Capital, LLC’s full portfolio or all institutional holders of BDQM.